Alimera Sciences Revenue, Growth & Competitor Profile

DBA ALIMERA

Company Profile & Annual Report for Alimera Sciences

Access the complete profile.

Alimera Sciences Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	6310 Town Square Suite 400 Alpharetta, GA 30005

Note: Revenues for privately held companies are statistical evaluations.


Alimera Sciences's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Alimera Sciences's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Alimera Sciences is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Alimera Sciences Annual Revenue and Growth Rate

Alimera Sciences	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Alimera Sciences's revenues are gauged from an analysis of company filings.

Alimera Sciences's Income Statement (based on Industry Averages)

Alimera Sciences P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Alimera Sciences is developing and marketing. Alimera Sciences doesn't have any recent trademark applications, indicating Alimera Sciences is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ACCESSALIMERA Providing information relating to ophthalmic pharmacological products via a website	06/08/2022
WE SEE MORE, TOGETHER Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Ophthalmic preparations; Pharmaceutical products for ophthalmological use	01/10/2022
DMEANDME providing a website featuring medical information about diabetic macular edema	12/02/2021

See all trademarks and details in the Full Report.

Market Share of Alimera Sciences's Largest Competitors

A competitive analysis shows these companies are in the same general field as Alimera Sciences, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Alimera Sciences. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
RAYBIOTECH	Peachtree Corners, GA	100
OMEGA BIO-TEK	Norcross, GA	97
ALIMERA SCIENCES	Alpharetta, GA	72
FOUNDATION FOR ATLANTA VETERANS EDUCATION & RESEARCH	Decatur, GA	44
ZYWIE	Johns Creek, GA	43
GENESIS BIOSCIENCES	Lawrenceville, GA	42

Future Competition: Alimera Sciences's Fastest Growing Competitors

These companies are in the same general field as Alimera Sciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)